About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Houston | 373 Studies

Clinical Trials HypertensionHouston

Hypertension Clinical Trials in Houston

Find 373 clinical trials for hypertension near Houston, Texas. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 241-260 of 373 trials

CompletedACT-293987 in Pulmonary Arterial HypertensionLong-term, single-arm, multicenter, open-label extension, Phase 3 study, to evaluate the safety and tolerability of ACT-293987 in patients with PAH who participated in the…NCT01112306·Mobile, Alabama and 156 others

Hypertension Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedTelmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of HypertensionTo identify dose combinations of telmisartan and ramipril that are more effective in reducing diastolic blood pressure than each of the respective monotherapies in patients with…NCT00281593·Glendale, Arizona and 118 others

TerminatedInhaled Nitric Oxide for Preterm Infants With Severe Respiratory FailureThis multicenter trial tested whether inhaled nitric oxide would reduce death or the need for oxygen in preterm infants (less than 34 weeks gestational age) with severe lung…NCT00016523·Birmingham, Alabama and 16 others

CompletedA Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)Study A011-09 is designed to assesses the efficacy and safety of sotatercept (ACE-011) relative to placebo in adults with pulmonary arterial hypertension (PAH).NCT03496207·Phoenix, Arizona and 42 others

CompletedEfficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial HypertensionThis study is an international, multi-center, randomized, double-blind, placebo-controlled study in subjects with PAH who are currently receiving approved therapy for their PAH…NCT00887978·Birmingham, Alabama and 61 others

CompletedClevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)The purpose of this study was to determine the safety of clevidipine for treating severely elevated blood pressure, defined as systolic (SBP) \>180 mmHg and/or diastolic blood…NCT00369837·Montgomery, Alabama and 13 others

RecruitingPediatric Pulmonary Hypertension Network (PPHNet) Informatics RegistryPatients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension…NCT02249923·Palo Alto, California and 13 others

CompletedStudy of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)This study will investigate the safety and efficacy of Relacorilant in combination with Pembrolizumab for Patients with Adrenocortical Carcinoma which Produces Too Much Stress…NCT04373265·Stanford, California and 5 others

CompletedA Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)To assess efficacy, and safety of a single sustained release dose of the OTX-TIC drug product (2 travoprost dose strengths) in subjects with Open Angle Glaucoma (OAG) or Ocular…NCT05335122·Dothan, Alabama and 29 others

CompletedA Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney DiseaseThis study will evaluate the efficacy and safety of CIN-107 for the treatment of hypertension in patients with uncontrolled hypertension (uHTN) and Chronic Kidney Disease (CKD).NCT05432167·Birmingham, Alabama and 70 others

TerminatedEfficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes MellitusThe purpose of this study is to evaluate the efficacy and safety of pioglitazone-azilsartan, once daily (QD), in subjects with type 2 diabetes mellitus with poor glycemic control.NCT00376181·Huntsville, Alabama and 72 others

TerminatedA Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and AdolescentsThe primary purpose of this study is to evaluate the blood pressure lowering effects of ramipril, an FDA-approved drug for the treatment of hypertension in adults, in children and…NCT00389519·Little Rock, Arkansas and 99 others

CompletedA Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled HypertensionThe purpose of this study is to evaluate the effect of ION904 on plasma angiotensinogen (AGT) in participants with uncontrolled hypertension.NCT05314439·Cypress, California and 7 others

CompletedBardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIATThis study assesses the safety and efficacy of bardoxolone methyl relative to placebo in patients with pulmonary hypertension to determine the recommended dose range, evaluate the…NCT02036970·Phoenix, Arizona and 31 others

CompletedBiomarker Guided Therapies in Stage A/B Heart FailureDespite advances in cardiovascular care, the occurrence of heart failure (HF) is steadily increasing.NCT02230891·Houston, Texas

CompletedREVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease ManagementThe REVEAL Registry™ is a multicenter, observational, U.S.-based study of the clinical course and disease management of pulmonary arterial hypertension (PAH) patients.NCT00370214·Birmingham, Alabama and 53 others

TerminatedTo Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.To demonstrate a dose response for 1 mg, 5 mg and 20 mg TID oral sildenafil for the treatment of subjects with PAH.NCT00430716·Phoenix, Arizona and 45 others

RecruitingPulmonary Hypertension Association RegistryThe PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).NCT04071327·Phoenix, Arizona and 51 others

CompletedPrimary Prevention of Hypertension in Obese AdolescentsThe purpose of this study is to examine the consequences of lowering serum uric acid in pre-hypertensive, obese adolescents pathways involved with how uric acid mediated…NCT00288158·Houston, Texas

CompletedRetrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United StatesThe Opsumit Users registry (OPUS; NCT02126943) was developed to characterize the safety profile of Opsumit and to describe clinical characteristics and outcomes of patients newly…NCT03197688·Phoenix, Arizona and 105 others

PreviousPage 13 of 19Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia